{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T18:51:43Z","timestamp":1784573503502,"version":"3.55.0"},"reference-count":36,"publisher":"Pharmaceutical Society of Japan","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological & Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2020,9,1]]},"DOI":"10.1248\/bpb.b20-00400","type":"journal-article","created":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T22:05:55Z","timestamp":1593036355000},"page":"1398-1406","source":"Crossref","is-referenced-by-count":20,"title":["Development of a Diagnostic Screening Strategy for Niemann\u2013Pick Diseases Based on Simultaneous Liquid Chromatography-Tandem Mass Spectrometry Analyses of <i>N<\/i>-Palmitoyl-<i>O<\/i>-phosphocholine-serine and Sphingosylphosphorylcholine"],"prefix":"10.1248","volume":"43","author":[{"given":"Anna","family":"Iwahori","sequence":"first","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Tohoku University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masamitsu","family":"Maekawa","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Tohoku University"},{"name":"Department of Pharmaceutical Sciences, Tohoku University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Narita","sequence":"additional","affiliation":[{"name":"Division of Child Neurology, Tottori University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akie","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Akita University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Tohoku University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiro","family":"Ogura","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Tohoku University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Tohoku University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Tohoku University"},{"name":"Department of Pharmaceutical Sciences, Tohoku University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuko","family":"Noguchi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Akita University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"Higaki","sequence":"additional","affiliation":[{"name":"Division of Functional Genomics, Research Centre for Bioscience and Technology, Faculty of Medicine, Tottori University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torayuki","family":"Okuyama","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Medicine, National Center for Child Health and Development"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Akita University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikatsu","family":"Eto","sequence":"additional","affiliation":[{"name":"Advanced Clinical Research Center, Institute for Neurological Disorders"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nariyasu","family":"Mano","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Tohoku University"},{"name":"Department of Pharmaceutical Sciences, Tohoku University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Crocker AC. The cerebral defect in Tay\u2013Sachs disease and Niemann\u2013Pick disease. J. Neurochem.<\/i>, 7<\/b>, 69\u201380 (1961).","DOI":"10.1111\/j.1471-4159.1961.tb13499.x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Brady RO, Kanfer JN, Mock MB, Fredrickson DS. The metabolism of sphingomyelin. II. Evidence of an enzymatic deficiency in Niemann\u2013Pick diseae. Proc. Natl. Acad. Sci. U.S.A.<\/i>, 55<\/b>, 366\u2013369 (1966).","DOI":"10.1073\/pnas.55.2.366"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Schuchman EH. The pathogenesis and treatment of acid sphingomyelinase-deficient Niemann\u2013Pick disease. J. Inherit. Metab. Dis.<\/i>, 30<\/b>, 654\u2013663 (2007).","DOI":"10.1007\/s10545-007-0632-9"},{"key":"4","unstructured":"4) Schuchman EH. Acid sphingomyelinase, cell membranes and human disease: lessons from Niemann\u2013Pick disease. FEBS Lett.<\/i>, 584<\/b>, 1895\u20131900 (2010)."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Wasserstein MP, Jones SA, Soran H, Diaz GA, Lippa N, Thurberg BL, Culm-Merdek K, Shamiyeh E, Inguilizian H, Cox GF, Puga AC. Successful within-patient dose escalation of olipudase alfa in acid sphingomyelinase deficiency. Mol. Genet. Metab.<\/i>, 116<\/b>, 88\u201397 (2015).","DOI":"10.1016\/j.ymgme.2015.05.013"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Vanier MT. Niemann\u2013Pick disease type C. Orphanet J. Rare Dis.<\/i>, 5<\/b>, 16 (2010).","DOI":"10.1186\/1750-1172-5-16"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Geberhiwot T, Moro A, Dardis A, et al.<\/i> Consensus clinical management guidelines for Niemann\u2013Pick disease type C. Orphanet J. Rare Dis.<\/i>, 13<\/b>, 50 (2018).","DOI":"10.1186\/s13023-018-0785-7"},{"key":"8","unstructured":"8) Carstea ED, Morris JA, Coleman KG, et al.<\/i> Niemann\u2013Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science<\/i>, 277<\/b>, 228\u2013231 (1997)."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Naureckiene S, Sleat DE, Lackland H, Fensom A, Vanier MT, Wattiaux R, Jadot M, Lobel P. Identification of HE1 as the second gene of Niemann\u2013Pick C disease. Science<\/i>, 290<\/b>, 2298\u20132301 (2000).","DOI":"10.1126\/science.290.5500.2298"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Kwon HJ, Abi-Mosleh L, Wang ML, Deisenhofer J, Goldstein JL, Brown MS, Infante RE. Structure of N-terminal domain of NPC1 reveals distinct subdomains for binding and transfer of cholesterol. Cell<\/i>, 137<\/b>, 1213\u20131224 (2009).","DOI":"10.1016\/j.cell.2009.03.049"},{"key":"11","unstructured":"11) Patterson MC, Vecchio D, Prady H, Abel L, Wraith JE. Miglustat for treatment of Niemann\u2013Pick C disease: a randomised controlled study. Lancet Neurol.<\/i>, 6<\/b>, 765\u2013772 (2007)."},{"key":"12","unstructured":"12) Ory DS, Ottinger EA, Farhat NY, et al.<\/i> Intrathecal 2-hydroxypropyl-beta-cyclodextrin decreases neurological disease progression in Niemann\u2013Pick disease, type C1: a non-randomised, open-label, phase 1-2 trial. Lancet<\/i>, 390<\/b>, 1758\u20131768 (2017)."},{"key":"13","unstructured":"13) Vanier MT, Latour P. Laboratory diagnosis of Niemann\u2013Pick disease type C: the filipin staining test. Methods Cell Biol.<\/i>, 126<\/b>, 357\u2013375 (2015)."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) McKay Bounford K, Gissen P. Genetic and laboratory diagnostic approach in Niemann\u2013Pick disease type C. J. Neurol.<\/i>, 261<\/b> (Suppl. 2), S569\u2013S575 (2014).","DOI":"10.1007\/s00415-014-7386-8"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Maekawa M, Mano N. Identification and evaluation of biomarkers for Niemann\u2013Pick disease type C based on chemical analysis techniques. Chromatography<\/i>, 41<\/b>, 19\u201329 (2020).","DOI":"10.15583\/jpchrom.2020.001"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Chuang WL, Pacheco J, Cooper S, McGovern MM, Cox GF, Keutzer J, Zhang XK. Lyso-sphingomyelin is elevated in dried blood spots of Niemann\u2013Pick B patients. Mol. Genet. Metab.<\/i>, 111<\/b>, 209\u2013211 (2014).","DOI":"10.1016\/j.ymgme.2013.11.012"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Welford RWD, Garzotti M, Marques Louren\u00e7o C, Mengel E, Marquardt T, Reunert J, Amraoui Y, Kolb SA, Morand O, Groenen P. Plasma lysosphingomyelin demonstrates great potential as a diagnostic biomarker for Niemann\u2013Pick disease type C in a retrospective study. PLOS ONE<\/i>, 9<\/b>, e114669 (2014).","DOI":"10.1371\/journal.pone.0114669"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Porter FD, Scherrer DE, Lanier MH, Langmade SJ, Molugu V, Gale SE, Olzeski D, Sidhu R, Dietzen DJ, Fu R, Wassif CA, Yanjanin NM, Marso SP, House J, Vite C, Schaffer JE, Ory DS. Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann\u2013Pick C1 disease. Sci. Transl. Med.<\/i>, 2<\/b>, 56ra81 (2010).","DOI":"10.1126\/scitranslmed.3001417"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Jiang X, Sidhu R, Porter FD, Yanjanin NM, Speak AO, te Vruchte DT, Platt FM, Fujiwara H, Scherrer DE, Zhang J, Dietzen DJ, Schaffer JE, Ory DS. A sensitive and specific LC-MS\/MS method for rapid diagnosis of Niemann\u2013Pick C1 disease from human plasma. J. Lipid Res.<\/i>, 52<\/b>, 1435\u20131445 (2011).","DOI":"10.1194\/jlr.D015735"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Mazzacuva F, Mills P, Mills K, Camuzeaux S, Gissen P, Nicoli E-R, Wassif C, te Vruchte D, Porter FD, Maekawa M, Mano N, Iida T, Platt F, Clayton PT. Identification of novel bile acids as biomarkers for the early diagnosis of Niemann\u2013Pick C disease. FEBS Lett.<\/i>, 590<\/b>, 1651\u20131662 (2016).","DOI":"10.1002\/1873-3468.12196"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Jiang X, Sidhu R, Mydock-McGrane L, Hsu F-F, Covey DF, Scherrer DE, Earley B, Gale SE, Farhat NY, Porter FD, Dietzen DJ, Orsini JJ, Berry-Kravis E, Zhang X, Reunert J, Marquardt T, Runz H, Giugliani R, Schaffer JE, Ory DS. Development of a bile acid-based newborn screen for Niemann\u2013Pick disease type C. Sci. Transl. Med.<\/i>, 8<\/b>, 337ra63 (2016).","DOI":"10.1126\/scitranslmed.aaf2326"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Maekawa M, Narita A, Jinnoh I, Iida T, Marquardt T, Mengel E, Eto Y, Clayton PT, Yamaguchi H, Mano N. Diagnostic performance evaluation of sulfate-conjugated cholesterol metabolites as urinary biomarkers of Niemann\u2013Pick disease type C. Clin. Chim. Acta<\/i>, 494<\/b>, 58\u201363 (2019).","DOI":"10.1016\/j.cca.2019.03.1610"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Maekawa M, Jinnoh I, Narita A, Iida T, Saigusa D, Iwahori A, Nittono H, Okuyama T, Eto Y, Ohno K, Clayton PT, Yamaguchi H, Mano N. Investigation of diagnostic performance of five urinary cholesterol metabolites for Niemann\u2013Pick disease type C. J. Lipid Res.<\/i>, 60<\/b>, 2074\u20132081 (2019).","DOI":"10.1194\/jlr.M093971"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Giese A-K, Mascher H, Grittner U, Eichler S, Kramp G, Lukas J, te Vruchte D, Al Eisa N, Cortina-Borja M, Porter FD, Platt FM, Rolfs A. A novel, highly sensitive and specific biomarker for Niemann\u2013Pick type C1 disease. Orphanet J. Rare Dis.<\/i>, 10<\/b>, 78 (2015).","DOI":"10.1186\/s13023-015-0274-1"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Maekawa M, Jinnoh I, Matsumoto Y, et al.<\/i> Structural determination of lysosphingomyelin-509 and discovery of novel class lipids from patients with Niemann\u2013Pick disease type C. Int. J. Mol. Sci.<\/i>, 20<\/b>, 5018 (2019).","DOI":"10.3390\/ijms20205018"},{"key":"26","unstructured":"26) Sidhu R, Mondjinou Y, Qian M, Song H, Kumar AB, Hong X, Hsu F-F, Dietzen DJ, Yanjanin NM, Porter FD, Berry-Kravis E, Vite CH, Gelb MH, Schaffer JE, Ory DS, Jiang X. N<\/i>-acyl-O<\/i>-phosphocholineserines: structures of a novel class of lipids that are biomarkers for Niemann\u2013Pick C1 disease. J. Lipid Res.<\/i>, 60<\/b>, 1410\u20131424 (2019)."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Deodato F, Boenzi S, Taurisano R, Semeraro M, Sacchetti E, Carrozzo R, Dionisi-Vici C. The impact of biomarkers analysis in the diagnosis of Niemann\u2013Pick C disease and acid sphingomyelinase deficiency. Clin. Chim. Acta<\/i>, 486<\/b>, 387\u2013394 (2018).","DOI":"10.1016\/j.cca.2018.08.039"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Voorink-Moret M, Goorden SMI, van Kuilenburg ABP, Wijburg FA, Ghauharali-van der Vlugt JMM, Beers-Stet FS, Zoetekouw A, Kulik W, Hollak CEM, Vaz FM. Rapid screening for lipid storage disorders using biochemical markers. Expert center data and review of the literature. Mol. Genet. Metab.<\/i>, 123<\/b>, 76\u201384 (2018).","DOI":"10.1016\/j.ymgme.2017.12.431"},{"key":"29","unstructured":"29) Maekawa M, Misawa Y, Sotoura A, Yamaguchi H, Togawa M, Ohno K, Nittono H, Kakiyama G, Iida T, Hofmann AF, Goto J, Shimada M, Mano N. LC\/ESI-MS\/MS analysis of urinary 3\u03b2-sulfooxy-7\u03b2-N<\/i>-acetylglucosaminyl-5-cholen-24-oic acid and its amides: new biomarkers for the detection of Niemann\u2013Pick type C disease. Steroids<\/i>, 78<\/b>, 967\u2013972 (2013)."},{"key":"30","unstructured":"30) Polo G, Burlina A, Furlan F, Kolamunnage T, Cananzi M, Giordano L, Zaninotto M, Plebani M, Burlina A. High level of oxysterols in neonatal cholestasis: a pitfall in analysis of biochemical markers for Niemann\u2013Pick type C disease. Clin. Chem. Lab. Med.<\/i>, 54<\/b>, 1221\u20131229 (2016)."},{"key":"31","unstructured":"31) Nury T, Zarrouk A, Ragot K, Debbabi M, Riedinger JM, Vejux A, Aubourg P, Lizard G. 7-Ketocholesterol is increased in the plasma of X-ALD patients and induces peroxisomal modifications in microglial cells: potential roles of 7-ketocholesterol in the pathophysiology of X-ALD. J. Steroid Biochem. Mol. Biol.<\/i>, 169<\/b>, 123\u2013136 (2017)."},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Ferderbar S, Pereira EC, Apolin\u00e1rio E, Bertolami MC, Faludi A, Monte O, Calliari LE, Sales JE, Gagliardi AR, Xavier HT, Abdalla DSP. Cholesterol oxides as biomarkers of oxidative stress in type 1 and type 2 diabetes mellitus. Diabetes Metab. Res. Rev.<\/i>, 23<\/b>, 35\u201342 (2007).","DOI":"10.1002\/dmrr.645"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Alkazemi D, Egeland G, Vaya J, Meltzer S, Kubow S. Oxysterol as a marker of atherogenic dyslipidemia in adolescence. J. Clin. Endocrinol. Metab.<\/i>, 93<\/b>, 4282\u20134289 (2008).","DOI":"10.1210\/jc.2008-0586"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Kuchar L, Sikora J, Gulinello ME, Poupetova H, Lugowska A, Malinova V, Jahnova H, Asfaw B, Ledvinova J. Quantitation of plasmatic lysosphingomyelin and lysosphingomyelin-509 for differential screening of Niemann\u2013Pick A\/B and C diseases. Anal. Biochem.<\/i>, 525<\/b>, 73\u201377 (2017).","DOI":"10.1016\/j.ab.2017.02.019"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Tanaka N, Nagayama H, Kobayashi H, Ikegami T, Hosoya K, Ishizuka N, Minakuchi H, Nakanishi K, Cabrera K, Lubda D. Monolithic silica columns for HPLC, micro-HPLC, and CEC. HRC J. High Resolut. Chromatogr.<\/i>, 23<\/b>, 111\u2013116 (2000).","DOI":"10.1002\/(SICI)1521-4168(20000101)23:1<111::AID-JHRC111>3.0.CO;2-H"},{"key":"36","unstructured":"36) \u201cBioanalytical method validation guidance for industry.\u201d: \u2039http:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/bioanalytical-method-validation-guidance-industry\u203a"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/43\/9\/43_b20-00400\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T03:23:43Z","timestamp":1599276223000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/43\/9\/43_b20-00400\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,1]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b20-00400","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,1]]}}}